Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes (Q38324344)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes |
scientific article |
Statements
1 reference
Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes (English)
1 reference
Yusheng Xiong
1 reference
Jian Guo
1 reference
Mari R Candelore
1 reference
Rui Liang
1 reference
Corey Miller
1 reference
Qing Dallas-Yang
1 reference
Guoqiang Jiang
1 reference
Peggy E McCann
1 reference
Sajjad A Qureshi
1 reference
Xinchun Tong
1 reference
Shiyao Sherrie Xu
1 reference
Jackie Shang
1 reference
Stella H Vincent
1 reference
Laurie M Tota
1 reference
Michael J Wright
1 reference
Xiaodong Yang
1 reference
Bei B Zhang
1 reference
James R Tata
1 reference
Emma R Parmee
1 reference
28 June 2012
1 reference
1 reference
Identifiers
1 reference